Can a supercomputer cure cancer?

When a team of dedicated scientists bolster their vision with Lenovo’s Infrastructure Solutions and 3rd Gen Intel Xeon processors, a new world of possibilities emerges.

Computational chemists Dr. Christoph Gorgulla, PhD and Dr. Gerhard Wagner, PhD demonstrate how a virtual drug-screening platform is paving the way to faster, more effective cancer treatments, and University Research Officer Dr. Scott Yockel showcases Cannon, the Lenovo-powered supercomputer that’s making it all possible.